Novonesis is drawing on China's research and manufacturing capabilities to develop biosolutions for global markets, as the Danish company deepens product development with local customers, a senior executive said.
"China is not just a market for applying innovation. It is also an important contributor to our global innovation network," Ye Xiaofeng, vice-president of planetary health biosolutions for Asia-Pacific at Novonesis, said in an interview with China Daily.
Chinese teams contribute to products for international markets, while solutions developed and tested locally could also serve overseas customers with similar needs, Ye said.
Its Tianjin full-scale wash lab facilities simulate washing conditions in different markets, adjusting for water hardness, temperature and stain types to support research for global customers.
Novonesis employs more than 1,000 people in China. Its China headquarters and research center are in Beijing, with factories in Tianjin, Taicang in Jiangsu province, and Shenyang in Liaoning province.
China's 15th Five-Year Plan (2026-30) identifies biomanufacturing as a future industry and calls for developing it into a new source of economic growth.
Ye said China's expanding biotechnology sector was creating both competition and opportunities for cooperation.
"Competition in China's cleaning industry is gradually shifting from a focus on scale and cost to a broader contest over quality, differentiation, consumer experience and sustainability," he said.
Wang Minyan, president of the China Cleaning Industry Association, said that reducing the industry's carbon footprint required changes to raw materials and formulations, as well as the water and electricity used during washing.
Closer cooperation among manufacturers, suppliers and research institutions would help bring more innovations into commercial use, she said.
Consumers want better stain removal and fabric care, alongside effective cleaning at lower temperatures and in shorter cycles, Ye said. Combining enzymes that target different stains helps tackle proteins, starches and fats in everyday laundry.
Novonesis invests about 11 percent of annual revenue in research and development. Products launched in the previous five years accounted for a quarter of group sales in 2025, according to the company's financial results.
Its global household care business generated 640.2 million euros ($704.67 million) in revenue in the first nine months of 2026, with organic sales growth of 7 percent year-on-year, driven by innovation, increased market penetration and pricing, the company said.
In a separate company study, an experimental liquid detergent with less surfactant and a blend of five enzymes improved overall stain removal compared with the reference formula. Surfactants help loosen and remove dirt. The combined cost of surfactants and enzymes was estimated to be lower, based on the company's estimates of market prices. The savings covered those ingredients only, and the performance results applied to the formulations and washing conditions tested.
"The bigger challenge is how to turn laboratory advantages into products that can be produced at scale, are cost-competitive and deliver benefits consumers can recognize," Ye said.
For detergent makers, Ye said, improving the whole formulation requires paying attention to ingredient compatibility, production processes and actual washing conditions.
"We are increasingly moving from providing a single ingredient to working with customers on formulation development, application testing, understanding and catering to consumer needs," he said.
